Where does Apton Biosystems, Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Apton Biosystems, Inc. ranks #25,760 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Apton Biosystems, Inc. hold?

Apton Biosystems, Inc. holds 10 US utility patents granted between 2019 and 2023, spanning 11 technology areas.

What is Apton Biosystems, Inc.'s Innovation Score?

Apton Biosystems, Inc. has an Innovation Score of 38.4 out of 100 (top 41% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Apton Biosystems, Inc.'s patent grant rate increasing or decreasing?

Apton Biosystems, Inc.'s recent grant velocity is +800% compared to the prior five-year period (grant years, not application filing dates). This indicates accelerating grant output.

What does claim depth mean for Apton Biosystems, Inc.'s patents?

Apton Biosystems, Inc.'s patents average 19.5 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Apton Biosystems, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Apton Biosystems, Inc.

Q: What technology areas does Apton Biosystems, Inc. focus on?

Apton Biosystems, Inc.'s top technology area is C12Q (Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Microbiological OR Enzymological Processes) with 9 patents, ranking #499 of 2,502 assignees active in that subclass. Grants appear in 11 CPC subclasses total.

USPTO PatentsView assignee record - 10 granted patents across 11 technology areas, recorded in grant years 2019–2023. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C12Q (Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Micr).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Apton ranks #25,760 of 49,997 tracked US assignees by granted-patent volume, with 10 patents across 11 technology areas.

#25,760
of 49,997 US assignees by volume: Top 41%
by Innovation Score (38.4/100): 19.5
avg claims per patent: +800%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R25760 · US Corporation #25,760 · 10 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-FOCUS · INNOV-THIN · CLAIMS-RICH · TYPE-USCORP · VEL-SURGE · BOOK-FULL

GRANTS-MICRO 10 grants
MID-PACK #25,760/49,997
PHOTO-FINISH APEM
CPC-FOCUS C12Q · 11 areas
INNOV-THIN 38.4/100
CLAIMS-RICH 19.5 claims/avg
TYPE-USCORP US Corporation
VEL-SURGE +800% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: APEM (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Apton’s 38.4 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 8.3 pts (22%) Velocity 6.7 pts (17%) Breadth 11.7 pts (30%) Claim depth 11.7 pts (30%)

Qualcomm Incorporated · highest

85
Apton Biosystems · this assignee

38
3D Lighting… · lowest

7

What this shows Apton's Innovation Score is 38.4/100 (top 41% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Apton?

Each dot is one of Apton’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Apton’s own 19.5 claims/patent is ABOVE the 16.3 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Apton vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Apton's grants concentrate

Apton Biosystems, Inc. is a focused PatentsView assignee: 11 CPC subclasses with 90% of grants classified under C12Q (Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Micr). Peak complete grant year is 2022 (4 grants) versus a trough of 1 in 2019. By volume, Apton sits between APEM and Araceli Biosciences.

Apton's three-year grant acceleration

Apton Biosystems, Inc. shows 5 grants in 2022–2024 against only 5 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

APEM

10
Aphp (Assistance…

10
Apos Medical Asse…

10
Applied Vision

10
Aqua BIO Technolo…

10
Aquahydrex PTY

10
AR Packaging Syst…

10
Araceli Bioscienc…

10
Apton Biosystems ◀

10

What this shows Apton holds 10 patents at rank #25,698, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Apton

By rank, the assignees closest to #25,698 in granted patent volume.

Leaders in C12Q (Measuring OR Testing Processes Involving Enzymes)

Other assignees with the most granted patents in Apton's primary technology class.

Apton's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

38 Top 41% higher than 59% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2019–2023

Grants by year

Teal-shaded recent years (2020–present) versus the 2019–2019 baseline. Full figures in the table below.

View data table

Apton Biosystems, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2019	1	10.0%
2020	2	20.0%
2021	2	20.0%
2022	4	40.0%
2023	1	10.0%

Which technologies does Apton Biosystems, Inc. patent most?

C12Q - Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Microbiological OR Enzymological Processes 9

G16B - Bioinformatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR Genetic OR Protein-related Data Processing IN Computational Molecular Biology 7

G06V - Image OR Video Recognition OR Understanding 6

G06F - Electric Digital Data Processing 6

G06T - Image Data Processing OR Generation, IN General 6

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 4

C40B - Combinatorial CHEMISTRY; Libraries, e.g. Chemical Libraries 2

G02B - Optical Elements, Systems OR Apparatus 1

H04N - Pictorial Communication, e.g. Television 1

G01D - Measuring NOT Specially Adapted FOR A Specific VARIABLE; Arrangements FOR Measuring TWO OR More Variables NOT Covered IN A Single Other SUBCLASS; Tariff Metering APPARATUS; Measuring OR Testing NOT Otherwise Provided FOR 1

H03M - CODING; DECODING; Code Conversion IN General 1

Top 11 of 11 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Apton Biosystems, Inc.'s patent record in context - here's where to go next.

Apton Biosystems, Inc.'s lead technology class is C12Q (Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Micr), 90% of its portfolio - see every assignee active in that class. Explore C12Q
Ranked #25,760 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Apton Biosystems, Inc. against APEM, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 38.4/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.